Back
Erasca, Inc. ERAS · News
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on ... Price15.61
Market Cap5.46 B
Float247.18 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscripts